Floatz logo

Folic Acid

Pancreatic Adenocarcinoma Metastatic

Clinica Universidad de Navarra, Universidad de NavarraSmall moleculePhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Pancreatic Adenocarcinoma Metastatic cohort.

Asset / SponsorPhaseRating
Atebimetinib
Immuneering Corporation
Phase 3B
ery001
ERYtech Pharma
Phase 2B
Zoldonrasib
Revolution Medicines, Inc.
Phase 3B
Mgnp
Immuneering Corporation
Phase 3B
Penpulimab
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2CCC

View all 20 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →